Thus, to examine whether there are common tumor-promoting factors between parent and resistant cells that enhance neutrophil survival, we tested the expression of pro-inflammatory factors such as IL-1β, CCL2, CCL3, CCL4, IL23, and iNOS in neutrophils. The gene discussed is NOS2; the disease is neoplasm.